Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
6,172,788
-
Share change
-
+762,368
-
Total reported value
-
$139,798,021
-
Price per share
-
$22.65
-
Number of holders
-
54
-
Value change
-
+$17,309,807
-
Number of buys
-
29
-
Number of sells
-
16
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q1 2017
As of 31 Mar 2017,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,172,788 shares.
The largest 10 holders included
Novo A/S, EMERALD ADVISERS INC/PA, BlackRock Inc., EMERALD MUTUAL FUND ADVISERS TRUST, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, FMR LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, and LBJ Family Wealth Advisors, Ltd..
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.